{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T01:50:15Z","timestamp":1773107415615,"version":"3.50.1"},"reference-count":91,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017949","name":"Health Commission of Shanxi Province","doi-asserted-by":"publisher","award":["2022060"],"award-info":[{"award-number":["2022060"]}],"id":[{"id":"10.13039\/100017949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>While the RNA-binding protein HuR is implicated in individual cancers, its comprehensive diagnostic, prognostic, and immunological roles across diverse cancer types remain unexplored.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We performed an integrated pan-cancer analysis of HuR using public datasets. This encompassed expression profiling, survival analysis, diagnostic accuracy assessment, immune microenvironment characterization, and drug sensitivity prediction. We investigated HuR\u2019s regulatory mechanisms through pathway correlation and differential gene expression analyses.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>HuR expression was consistently elevated across multiple cancers and correlated with poor patient prognosis. It demonstrated high diagnostic accuracy (&gt;85%) via TMB\/PD-L1 biomarkers. High HuR expression was associated with an immunosuppressive tumor microenvironment and reduced efficacy of immune checkpoint inhibitors, establishing it as a key immunoregulatory biomarker. HuR also predicted sensitivity to cell cycle inhibitors and other pathway-targeted drugs. Mechanistically, HuR drives malignancy by dysregulating core processes: cell cycle progression, immune evasion, and cellular metabolism.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Our pan-cancer analysis establishes HuR as a consistently upregulated oncogenic driver across malignancies, functioning as a potential universal biomarker for prognosis and diagnosis. Its critical roles in modulating the immune response and predicting therapeutic sensitivity highlight its importance for personalized cancer treatment strategies. HuR orchestrates tumorigenesis and malignant progression by integrally regulating vital cellular processes.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pcbi.1013374","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T17:36:17Z","timestamp":1756143377000},"page":"e1013374","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated pan-cancer analysis of RNA binding protein HuR investigates its biomarker potential in prognosis, immunotherapy, and drug sensitivity"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6780-4330","authenticated-orcid":true,"given":"Jian","family":"Peng","sequence":"first","affiliation":[]},{"given":"Jichuan","family":"Quan","sequence":"additional","affiliation":[]},{"given":"Xiaoru","family":"Wang","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"issue":"3","key":"pcbi.1013374.ref001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"F Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"pcbi.1013374.ref002","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"RL Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"pcbi.1013374.ref003","first-page":"224","article-title":"Global cancer statistics: A healthy population relies on population health","volume":"74","author":"N Jokhadze","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"pcbi.1013374.ref004","first-page":"221","article-title":"Cancer incidence and mortality in China, 2022","volume":"46","author":"RS Zheng","year":"2024","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"7","key":"pcbi.1013374.ref005","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"W Cao","year":"2021","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"pcbi.1013374.ref006","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molcel.2020.03.011","article-title":"How RNA-Binding Proteins Interact with RNA: Molecules and Mechanisms","volume":"78","author":"M Corley","year":"2020","journal-title":"Mol Cell"},{"issue":"5","key":"pcbi.1013374.ref007","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41576-022-00550-0","article-title":"The nexus between RNA-binding proteins and their effectors","volume":"24","author":"S He","year":"2023","journal-title":"Nat Rev Genet"},{"issue":"9","key":"pcbi.1013374.ref008","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41570-020-0201-4","article-title":"Inhibition of RNA-binding proteins with small molecules","volume":"4","author":"P Wu","year":"2020","journal-title":"Nat Rev Chem"},{"key":"pcbi.1013374.ref009","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.semcancer.2022.03.025","article-title":"RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer","volume":"86","author":"W Li","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"pcbi.1013374.ref010","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.semcancer.2022.01.010","article-title":"RNA-binding proteins: Underestimated contributors in tumorigenesis","volume":"86","author":"Y Zhao","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"pcbi.1013374.ref011","doi-asserted-by":"crossref","first-page":"107390","DOI":"10.1016\/j.pharmthera.2019.07.001","article-title":"Cancer the\u2019RBP\u2019eutics-RNA-binding proteins as therapeutic targets for cancer","volume":"203","author":"S Mohibi","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"1","key":"pcbi.1013374.ref012","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13045-020-00927-w","article-title":"RNA-binding proteins in tumor progression","volume":"13","author":"H Qin","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"1","key":"pcbi.1013374.ref013","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41392-022-01033-8","article-title":"RNA-binding protein ZCCHC4 promotes human cancer chemoresistance by disrupting DNA-damage-induced apoptosis","volume":"7","author":"H Zhu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"pcbi.1013374.ref014","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1038\/s41467-023-44126-w","article-title":"RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing","volume":"14","author":"M Maurin","year":"2023","journal-title":"Nat Commun"},{"issue":"21","key":"pcbi.1013374.ref015","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/s41388-023-02687-6","article-title":"Phase separation of DDX21 promotes colorectal cancer metastasis via MCM5-dependent EMT pathway","volume":"42","author":"H Gao","year":"2023","journal-title":"Oncogene"},{"issue":"21","key":"pcbi.1013374.ref016","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1158\/0008-5472.CAN-23-0972","article-title":"Targeting the RNA-Binding Protein HuR in Cancer","volume":"83","author":"JM Finan","year":"2023","journal-title":"Cancer Res"},{"issue":"3","key":"pcbi.1013374.ref017","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1581","article-title":"Understanding and targeting the disease-related RNA binding protein human antigen R (HuR)","volume":"11","author":"CW Schultz","year":"2020","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"11","key":"pcbi.1013374.ref018","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1093\/cvr\/cvad077","article-title":"Human antigen R regulates autophagic flux by stabilizing autophagy-associated mRNA in calcific aortic valve disease","volume":"119","author":"J Fang","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"3","key":"pcbi.1013374.ref019","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911011","article-title":"MicroRNA exporter HuR clears the internalized pathogens by promoting pro-inflammatory response in infected macrophages","volume":"12","author":"A Goswami","year":"2020","journal-title":"EMBO Mol Med"},{"issue":"9","key":"pcbi.1013374.ref020","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1158\/0008-5472.CAN-15-1726","article-title":"HuR Small-Molecule Inhibitor Elicits Differential Effects in Adenomatosis Polyposis and Colorectal Carcinogenesis","volume":"77","author":"M Lang","year":"2017","journal-title":"Cancer Res"},{"issue":"3","key":"pcbi.1013374.ref021","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41419-021-03514-0","article-title":"Hepatic HuR protects against the pathogenesis of non-alcoholic fatty liver disease by targeting PTEN","volume":"12","author":"M Tian","year":"2021","journal-title":"Cell Death Dis"},{"issue":"9","key":"pcbi.1013374.ref022","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/abbs\/gmx071","article-title":"Emerging role of HuR in inflammatory response in kidney diseases","volume":"49","author":"J Shang","year":"2017","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"1","key":"pcbi.1013374.ref023","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/s12967-023-04298-x","article-title":"Targeting RNA-binding protein HuR to inhibit the progression of renal tubular fibrosis","volume":"21","author":"Z Huang","year":"2023","journal-title":"J Transl Med"},{"issue":"1","key":"pcbi.1013374.ref024","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1038\/s41467-024-49874-x","volume":"15","author":"D Adamoski","year":"2024","journal-title":"Nature Communications"},{"issue":"12","key":"pcbi.1013374.ref025","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1038\/s41388-021-01689-6","article-title":"HuR up-regulates cell surface PD-L1 via stabilizing CMTM6 transcript in cancer","volume":"40","author":"Y Liu","year":"2021","journal-title":"Oncogene"},{"issue":"2","key":"pcbi.1013374.ref026","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1515\/jtim-2025-0009","article-title":"Deciphering the role of ELAVL1: Insights from pan-cancer multiomics analyses with emphasis on nasopharyngeal carcinoma","volume":"13","author":"J Xie","year":"2025","journal-title":"J Transl Int Med"},{"issue":"7","key":"pcbi.1013374.ref027","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1172\/JCI130379","article-title":"HuR\/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis","volume":"130","author":"M Palomo-Irigoyen","year":"2020","journal-title":"J Clin Invest"},{"key":"pcbi.1013374.ref028","doi-asserted-by":"crossref","first-page":"114179","DOI":"10.1016\/j.addr.2022.114179","article-title":"The RNA-binding protein HuR in human cancer: A friend or foe?","volume":"184","author":"X Wu","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"pcbi.1013374.ref029","doi-asserted-by":"crossref","first-page":"114068","DOI":"10.1016\/j.addr.2021.114068","article-title":"Drug delivery approaches for HuR-targeted therapy for lung cancer","volume":"180","author":"R Raguraman","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"pcbi.1013374.ref030","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The genotype-tissue expression (GTEx) project","volume":"45","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"pcbi.1013374.ref031","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1467-985X.2010.00676_9.x","article-title":"ggplot2: Elegant Graphics for Data Analysis","volume":"174","author":"C Ginestet","year":"2011","journal-title":"Journal of the Royal Statistical Society Series A: Statistics in Society"},{"issue":"2","key":"pcbi.1013374.ref032","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.12.023","article-title":"Quantitative Proteomics of the Cancer Cell Line Encyclopedia","volume":"180","author":"DP Nusinow","year":"2020","journal-title":"Cell"},{"issue":"2","key":"pcbi.1013374.ref033","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/bioinformatics\/btab561","article-title":"UCSCXenaShiny: an R\/CRAN package for interactive analysis of UCSC Xena data","volume":"38","author":"S Wang","year":"2022","journal-title":"Bioinformatics"},{"key":"pcbi.1013374.ref034","volume-title":"Survminer: Drawing survival curves using \u2018ggplot2\u2019","author":"A Kassambara","year":"2016"},{"key":"pcbi.1013374.ref035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"X Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"pcbi.1013374.ref036","first-page":"264","article-title":"Current treatment and recent progress in gastric cancer","volume":"71","author":"SS Joshi","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"pcbi.1013374.ref037","volume-title":"Ggsci: Scientific journal and sci-fi themed color palettes for \u2018ggplot2\u2019","author":"N Xiao","year":"2016"},{"key":"pcbi.1013374.ref038","doi-asserted-by":"crossref","first-page":"827921","DOI":"10.3389\/fimmu.2022.827921","article-title":"Biological Characteristics and Clinical Significance of Soluble PD-1\/PD-L1 and Exosomal PD-L1 in Cancer","volume":"13","author":"M Niu","year":"2022","journal-title":"Front Immunol"},{"key":"pcbi.1013374.ref039","volume-title":"ggpmisc: Miscellaneous Extensions to \u2018ggplot2\u2019","year":"2016"},{"key":"pcbi.1013374.ref040","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"K Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"pcbi.1013374.ref041","volume-title":"ggpubr: \u2018ggplot2\u2019 Based Publication Ready Plots","year":"2017"},{"key":"pcbi.1013374.ref042","doi-asserted-by":"crossref","first-page":"1008146","DOI":"10.3389\/fimmu.2022.1008146","article-title":"Comprehensive analysis of cuproptosis-related genes in immune infiltration and diagnosis in ulcerative colitis","volume":"13","author":"J Huang","year":"2022","journal-title":"Front Immunol"},{"key":"pcbi.1013374.ref043","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"S H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"pcbi.1013374.ref044","volume-title":"Hmisc: Harrell Miscellaneous","author":"FHC Dupont","year":"2015"},{"issue":"1","key":"pcbi.1013374.ref045","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"E Becht","year":"2016","journal-title":"Genome Biol"},{"issue":"1","key":"pcbi.1013374.ref046","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12943-023-01752-8","article-title":"Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis","volume":"22","author":"Y Qin","year":"2023","journal-title":"Mol Cancer"},{"key":"pcbi.1013374.ref047","article-title":"Make interactive complex heatmaps in R","author":"Z Gu","year":"2021","journal-title":"Bioinformatics"},{"issue":"1","key":"pcbi.1013374.ref048","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41467-017-02391-6","article-title":"Perturbation-response genes reveal signaling footprints in cancer gene expression","volume":"9","author":"M Schubert","year":"2018","journal-title":"Nat Commun"},{"issue":"12","key":"pcbi.1013374.ref049","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1158\/2159-8290.CD-20-0522","article-title":"Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors","volume":"10","author":"D Sha","year":"2020","journal-title":"Cancer Discov"},{"issue":"11","key":"pcbi.1013374.ref050","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/s41419-020-03140-2","article-title":"PD-L1 degradation pathway and immunotherapy for cancer","volume":"11","author":"Q Gou","year":"2020","journal-title":"Cell Death Dis"},{"issue":"1","key":"pcbi.1013374.ref051","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"X Lin","year":"2024","journal-title":"Mol Cancer"},{"issue":"18","key":"pcbi.1013374.ref052","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"DC Hinshaw","year":"2019","journal-title":"Cancer Research"},{"issue":"3","key":"pcbi.1013374.ref053","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41576-020-00302-y","article-title":"RNA-binding proteins in human genetic disease","volume":"22","author":"F Gebauer","year":"2021","journal-title":"Nat Rev Genet"},{"issue":"5","key":"pcbi.1013374.ref054","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrm.2017.130","article-title":"A brave new world of RNA-binding proteins","volume":"19","author":"MW Hentze","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"pcbi.1013374.ref055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2019.01.010","article-title":"Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia","volume":"35","author":"E Wang","year":"2019","journal-title":"Cancer Cell"},{"key":"pcbi.1013374.ref056","doi-asserted-by":"crossref","first-page":"103074","DOI":"10.1016\/j.ebiom.2020.103074","article-title":"A pan-cancer analysis of HER2 index revealed transcriptional pattern for precise selection of HER2-targeted therapy","volume":"62","author":"Z Li","year":"2020","journal-title":"EBioMedicine"},{"issue":"1","key":"pcbi.1013374.ref057","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12929-023-00915-5","article-title":"A transcriptomic pan-cancer signature for survival prognostication and prediction of immunotherapy response based on endothelial senescence","volume":"30","author":"Z Wu","year":"2023","journal-title":"J Biomed Sci"},{"issue":"11","key":"pcbi.1013374.ref058","first-page":"5094","article-title":"Oncogenic and immunological values of RBM34 in osteosarcoma and its pan-cancer analysis","volume":"13","author":"W Zhang","year":"2023","journal-title":"Am J Cancer Res"},{"key":"pcbi.1013374.ref059","doi-asserted-by":"crossref","first-page":"122527","DOI":"10.1016\/j.lfs.2024.122527","article-title":"Comprehensive pan-cancer analysis identifies the RNA-binding protein LRPPRC as a novel prognostic and immune biomarker","volume":"343","author":"Z Wu","year":"2024","journal-title":"Life Sci"},{"issue":"7","key":"pcbi.1013374.ref060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1158\/1541-7786.MCR-15-0448","article-title":"HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells","volume":"14","author":"C Romeo","year":"2016","journal-title":"Mol Cancer Res"},{"issue":"1","key":"pcbi.1013374.ref061","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12943-017-0751-3","article-title":"The Jun\/miR-22\/HuR regulatory axis contributes to tumourigenesis in colorectal cancer","volume":"17","author":"Y Liu","year":"2018","journal-title":"Mol Cancer"},{"issue":"1","key":"pcbi.1013374.ref062","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12951-016-0201-1","article-title":"Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration","volume":"14","author":"R Muralidharan","year":"2016","journal-title":"J Nanobiotechnology"},{"issue":"23","key":"pcbi.1013374.ref063","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1158\/1078-0432.CCR-07-1432","article-title":"Prognostic role of HuR in hereditary breast cancer","volume":"13","author":"M Heinonen","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"1","key":"pcbi.1013374.ref064","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12943-020-01208-3","article-title":"Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p\/HUR\/VEGF axis and suppressing HSP90 degradation","volume":"19","author":"M Xie","year":"2020","journal-title":"Mol Cancer"},{"issue":"3","key":"pcbi.1013374.ref065","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1469","article-title":"Complex HuR function in pancreatic cancer cells","volume":"9","author":"JR Brody","year":"2018","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"1","key":"pcbi.1013374.ref066","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13062-023-00397-3","article-title":"Circular RNA hsa_circ_0067842 facilitates tumor metastasis and immune escape in breast cancer through HuR\/CMTM6\/PD-L1 axis","volume":"18","author":"J Li","year":"2023","journal-title":"Biol Direct"},{"issue":"5","key":"pcbi.1013374.ref067","doi-asserted-by":"crossref","first-page":"112419","DOI":"10.1016\/j.celrep.2023.112419","article-title":"Time-dependent regulation of cytokine production by RNA binding proteins defines T cell effector function","volume":"42","author":"B Popovi\u0107","year":"2023","journal-title":"Cell Rep"},{"issue":"7","key":"pcbi.1013374.ref068","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41418-021-00925-6","article-title":"TLR4 downregulation by the RNA-binding protein PUM1 alleviates cellular aging and osteoarthritis","volume":"29","author":"DS Yoon","year":"2022","journal-title":"Cell Death Differ"},{"key":"pcbi.1013374.ref069","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fimmu.2016.00161","article-title":"Post-transcriptional Regulation of Immunological Responses through Riboclustering","volume":"7","author":"K Ganguly","year":"2016","journal-title":"Front Immunol"},{"key":"pcbi.1013374.ref070","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev-immunol-101819-075147","article-title":"Control of RNA Stability in Immunity","volume":"39","author":"S Akira","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"pcbi.1013374.ref071","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.semcancer.2022.03.017","article-title":"Roles of RNA-binding proteins in immune diseases and cancer","volume":"86","author":"S Hashimoto","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"pcbi.1013374.ref072","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1038\/ncomms5186","article-title":"RNA-binding proteins regulate the expression of the immune activating ligand MICB","volume":"5","author":"D Nachmani","year":"2014","journal-title":"Nat Commun"},{"issue":"6","key":"pcbi.1013374.ref073","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.apsb.2023.04.002","article-title":"Mevalonate improves anti-PD-1\/PD-L1 efficacy by stabilizing CD274 mRNA","volume":"13","author":"W Zhang","year":"2023","journal-title":"Acta Pharm Sin B"},{"issue":"12","key":"pcbi.1013374.ref074","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s11427-021-2085-9","article-title":"TERC suppresses PD-L1 expression by downregulating RNA binding protein HuR","volume":"65","author":"H Jin","year":"2022","journal-title":"Sci China Life Sci"},{"issue":"9","key":"pcbi.1013374.ref075","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41419-022-05164-2","article-title":"LINC00152 induced by TGF-\u03b2 promotes metastasis via HuR in lung adenocarcinoma","volume":"13","author":"W Xu","year":"2022","journal-title":"Cell Death Dis"},{"key":"pcbi.1013374.ref076","doi-asserted-by":"crossref","first-page":"100154","DOI":"10.1074\/jbc.RA120.014894","article-title":"RNA-binding proteins La and HuR cooperatively modulate translation repression of PDCD4 mRNA","volume":"296","author":"R Kumar","year":"2021","journal-title":"J Biol Chem"},{"issue":"3","key":"pcbi.1013374.ref077","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202305026","article-title":"TNF and IFN\u03b3-induced cell death requires IRF1 and ELAVL1 to promote CASP8 expression","volume":"223","author":"B Deng","year":"2024","journal-title":"J Cell Biol"},{"issue":"1","key":"pcbi.1013374.ref078","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1172\/JCI45021","article-title":"Myeloid cell expression of the RNA-binding protein HuR protects mice from pathologic inflammation and colorectal carcinogenesis","volume":"122","author":"A Yiakouvaki","year":"2012","journal-title":"J Clin Invest"},{"issue":"6","key":"pcbi.1013374.ref079","doi-asserted-by":"crossref","first-page":"103580","DOI":"10.1016\/j.drudis.2023.103580","article-title":"RNA-binding proteins in cancer drug discovery","volume":"28","author":"JB Bertoldo","year":"2023","journal-title":"Drug Discov Today"},{"key":"pcbi.1013374.ref080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2022.06.008","article-title":"Targeting the \u201cundruggable\u201d: RNA-binding proteins in the spotlight in cancer therapy","volume":"86","author":"C Mir","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"pcbi.1013374.ref081","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/nar\/gkac139","article-title":"Small molecule targeting CELF1 RNA-binding activity to control HSC activation and liver fibrosis","volume":"50","author":"Y Tan","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pcbi.1013374.ref082","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12885-023-11791-5","article-title":"Exosomes derived from cancer-associated fibroblasts promote tumorigenesis, metastasis and chemoresistance of colorectal cancer by upregulating circ_0067557 to target Lin28","volume":"24","author":"C Yang","year":"2024","journal-title":"BMC Cancer"},{"issue":"7","key":"pcbi.1013374.ref083","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/1535-7163.MCT-18-0945","article-title":"The RNA-Binding Protein HuR Confers Oxaliplatin Resistance of Colorectal Cancer By Upregulating CDC6","volume":"18","author":"J Cai","year":"2019","journal-title":"Mol Cancer Ther"},{"issue":"18","key":"pcbi.1013374.ref084","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1128\/MCB.05639-11","article-title":"Translational control of TOP2A influences doxorubicin efficacy","volume":"31","author":"S Srikantan","year":"2011","journal-title":"Mol Cell Biol"},{"issue":"19","key":"pcbi.1013374.ref085","doi-asserted-by":"crossref","first-page":"10405","DOI":"10.1093\/nar\/gky696","article-title":"MIR100 host gene-encoded lncRNAs regulate cell cycle by modulating the interaction between HuR and its target mRNAs","volume":"46","author":"Q Sun","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"pcbi.1013374.ref086","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1093\/nar\/gky214","article-title":"Long noncoding RNA OCC-1 suppresses cell growth through destabilizing HuR protein in colorectal cancer","volume":"46","author":"Y Lan","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"pcbi.1013374.ref087","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"MJ Goldman","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"10","key":"pcbi.1013374.ref088","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The Cancer Genome Atlas Pan-Cancer analysis project","volume":"45","author":"JN Weinstein","year":"2013","journal-title":"Nat Genet"},{"issue":"7757","key":"pcbi.1013374.ref089","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the Cancer Cell Line Encyclopedia","volume":"569","author":"M Ghandi","year":"2019","journal-title":"Nature"},{"issue":"6509","key":"pcbi.1013374.ref090","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx Consortium atlas of genetic regulatory effects across human tissues","volume":"369","author":"GTEx Consortium","year":"2020","journal-title":"Science"},{"issue":"6220","key":"pcbi.1013374.ref091","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"M Uhl\u00e9n","year":"2015","journal-title":"Science"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1013374","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T17:36:31Z","timestamp":1756143391000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1013374"}},"subtitle":[],"editor":[{"given":"Pramod","family":"Shinde","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":91,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1013374","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]}}}